BRNS

Barinthus Biotherapeutics

13 hedge funds and large institutions have $23.2M invested in Barinthus Biotherapeutics in 2022 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 4 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

more funds holding in top 10

Funds holding in top 10:

more first-time investments, than exits

New positions opened: | Existing positions closed:

more capital invested

Capital invested by funds: $ → $

more funds holding

Funds holding:

3.65% more ownership

Funds ownership: 13.28%16.93% (+3.6%)

75% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 4

Holders
13
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change

Top Buyers

1 +$6.32M
2 +$1.19M
3 +$19.9K

Top Sellers

1 -$55.2K
2 -$32.3K
3 -$6.47K
Name Holding Trade Value Shares
Change
Change in
Stake
1
$6.74M
2
$6.32M
3
$2.86M
4
$2.67M
5
$2.42M
6
$1.19M
7
$480K
8
$273K
9
$178K
10
$61K
11
$4.35K
12
$2K